Summary
Whole-genome sequencing of 7,851 parent–offspring families linked distinct assisted reproductive technology procedures and parental age with de novo mutations associated with gestational duration and other birth outcomes.
A whole-genome analysis of 7,851 parent–offspring families has connected parental reproductive factors with newly arising mutations in children and with early birth outcomes. The findings were reported in a Nature Medicine research briefing published on 14 September 2026.
The analysis identified parent-of-origin and post-zygotic de novo mutations associated with distinct assisted reproductive technology (ART) procedures. These associations were reported independently of parental age at conception. It also found that increased paternal mutational burden statistically mediated the effects of advanced parental age and ART on gestational duration and other birth outcomes.
What the analysis measured
A de novo mutation (DNM) is a DNA change that arises in the lineage leading to a child rather than being inherited as an existing parental variant. By sequencing the genomes of both parents and their offspring, researchers can identify mutations that are new in the child and examine whether they are associated with the maternal or paternal lineage.
The analysis also distinguished post-zygotic mutations. These arise after fertilisation and may therefore occur in only a subset of the cells that develop in the embryo. Their timing and distribution can affect how they relate to development and disease.
Whole-genome sequencing allowed the researchers to examine these mutation categories alongside parental age, ART and birth outcomes across the 7,851 families. The briefing specifically reports associations between de novo mutation patterns and distinct ART procedures, with the relationship remaining after accounting for parental age at conception.
The link between mutation burden and birth outcomes
The reported results point particularly to the paternal contribution. Increased paternal mutational burden statistically mediated the effects of advanced parental age and ART on gestational duration and other birth outcomes.
In this setting, statistical mediation means that the study’s model identified paternal mutation burden as an intermediate factor in the relationship between parental reproductive factors and the measured outcomes. It provides a way to test whether part of an association can be statistically accounted for by another variable; it is not, by itself, a demonstrated biological cause-and-effect pathway.
The finding builds on the established relationship between paternal age and the accumulation of new mutations in sperm. It extends that line of investigation by considering parental age and ART together with mutations that arise in the parental germline or after fertilisation, rather than treating birth outcomes as independent of the child’s newly formed genetic variation.
Why the finding matters
De novo mutations are relevant to offspring health because a newly arising change can affect a gene or regulatory region involved in development or disease. The importance of any individual mutation depends on its location, biological effect and distribution among cells. The current analysis does not reduce those varied possibilities to a single genetic risk measure; instead, it identifies a population-level relationship between mutational burden and early-life outcomes.
The work is therefore meaningful as an integrative genomic analysis: it places parental reproductive factors, mutation origin and gestational or birth outcomes in one framework. The reported mediation result suggests that paternal mutational burden may be one route through which parental age and ART are connected with variation in these outcomes.
The evidence should be read as a family-genome association analysis with model-based mediation estimates. The available briefing names distinct ART procedures and refers to gestational duration and other birth outcomes, but it does not provide the procedure names, mutation-specific diagnoses or effect estimates needed to translate the findings into an individual child’s risk.